TEK and neoplasm: This can also recruit Tie2-expressing monocytes (TEMs) and tumor-associated macrophages (TAMs) to promote angiogenesis and disrupt the temporary balance achieved by anti-angiogenic therapy, leading to chaotic and disordered growth of tumor vasculature (181).